Development of a New Class of CXCR4-Targeting Radioligands Based on the Endogenous Antagonist EPI-X4 for Oncological Applications

[Image: see text] The peptide fragment of human serum albumin that was identified as an inhibitor of C–X–C motif chemokine receptor 4 (CXCR4), termed EPI-X4, was investigated as a scaffold for the development of CXCR4-targeting radio-theragnostics. Derivatives of its truncated version JM#21 (ILRWSRK...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaonkar, Raghuvir Haridas, Schmidt, Yannik Tim, Mansi, Rosalba, Almeida-Hernandez, Yasser, Sanchez-Garcia, Elsa, Harms, Mirja, Münch, Jan, Fani, Melpomeni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350915/
https://www.ncbi.nlm.nih.gov/pubmed/37328158
http://dx.doi.org/10.1021/acs.jmedchem.3c00131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350915/
https://www.ncbi.nlm.nih.gov/pubmed/37328158
http://dx.doi.org/10.1021/acs.jmedchem.3c00131

Ejemplares similares